0001225208-15-019103.txt : 20151002
0001225208-15-019103.hdr.sgml : 20151002
20151002162311
ACCESSION NUMBER: 0001225208-15-019103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151001
FILED AS OF DATE: 20151002
DATE AS OF CHANGE: 20151002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACMILLAN STEPHEN P
CENTRAL INDEX KEY: 0001239351
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 151140636
4
1
doc4.xml
X0306
4
2015-10-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001239351
MACMILLAN STEPHEN P
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
Deferred Stock Units
2015-10-01
4
A
0
674.0000
0.0000
A
Common Stock
674.0000
6420.0000
D
Stock Option (Right to Buy)
16.6900
2015-10-01
4
A
0
2151.0000
0.0000
A
2025-10-01
Common Stock
2151.0000
2151.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Reflects a value of $11,250 divided by the closing price of common stock on the date of grant.
Deferred stock units were granted in lieu of half of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
Reporting person received half of the cash compensation for the third quarter of 2015 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2016 annual meeting of stockholders.
/s/ Lee G. Giguere, Attorney-in-Fact
2015-10-02